News
Sarepta Therapeutics Comments on Erroneous Submission to US FDA Adverse Event Reporting System (FAERS)
Sarepta Therapeutics, Inc, the leader in precision genetic medicine for rare diseases, was informed earlier that an adverse event report was erroneously submitted to...
Industry Reports
Clariant Chemicals Q1 profits up by 20.3% Sales grew by 11.9%
Clariant Chemicals (India) Limited reported profit before tax of Rs. 18.4 crore for the quarter ended June 2019, as compared to profit before tax...
Drug Research
Vesselon Acquires FDA-Approved Lipid Microsphere Drug Imagent For Therapeutic Platform
Vesselon, an oncology therapeutics company, announced the acquisition of an FDA-approved drug Imagent®. Vesselon will use Imagent to create novel therapeutic complexes in four...
News
Zenith Epigenetics and China-Based Newsoara Biopharma Announce Licensing Agreement for ZEN-3694
Zenith Capital Corp. announced that Zenith Epigenetics Ltd. , a wholly-owned subsidiary of Zenith Capital, has entered into a licensing agreement with Newsoara BioPharma...
Press Releases
Aevi Genomic Medicine Enters into License Agreement with AstraZeneca for Anti-IL-18 Antibody
Aevi Genomic Medicine, Inc. announced that it has obtained the right to exercise an exclusive global license for MEDI2338, a Phase 2-ready fully human...
News
Aucta Pharmaceuticals Announces Licensing of Vigabatrin for Oral Solution in China
Aucta Pharmaceuticals, Inc. ,a technology based company focusing on the development and commercialization of Branded Specialty Products, announced that the Company has entered into...
IT & Data Management
Boston Analytical Continues Expansion with Office in Cambridge MA
Boston Analytical, a leading provider of analytical and microbiological testing to the pharmaceutical industry, has opened an office in downtown Cambridge. This expansion comes...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read